1Hospices Civils de Lyon, Service d’Hématologie Biologique, Pierre Bénite, France
2INSERM1052, CNRS 5286, Université Claude Bernard, Faculté de Médecine Lyon-Sud Charles Mérieux, Université de Lyon, Pierre Bénite, France
3Service d’Hématologie Biologique, Centre Hospitalier Universitaire de Nantes, France
4Institut de Pathologie, Hôpital Universitaire de Lausanne (CHUV), Lausanne, Suisse
5CHU de Bordeaux et Université de Bordeaux, INSERM U 1053, Bordeaux, France
6Laboratoire d’Hématologie, Pôle de Biologie, CHU Rennes; INSERM, UMR U1236, Université Rennes1, Rennes, France
7Hospices Civils de Lyon, Service d’Hématologie Clinique, Pierre Bénite, France
8AP-HP, Hôpital Pitié-Salpêtrière, Service d’Hématologie Biologique, et Sorbonne Université, UMR-S 1138, Paris, France
9INSERM 1209, CNRS UMR 5309, Universite Grenoble-Alpes, Institut Pour l’Avancee des Biosciences, Grenoble, France
10Centre d’Innovation en Genetique et Epigenetique Onco-Hematologique, Centre Hospitalier de Dijon-Bourgogne, Dijon, France
11AP-HP, Hôpital Saint-Louis, Hémato-Oncologie, Paris, France
12Diderot Université, Sorbonne Paris-Cité, Paris, France
13Descartes Université, Paris, France
14Service d’Hématologie Adultes, Hôpital Necker-Enfants Malades, AP-HP, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France
15APHP Necker Enfants Malades, Université Paris Descartes, Institut Necker-Enfants Malades (INEM) et INSERM UMR 1151, Paris, France
16Université Lille, Inserm, CHU Lille, UMR-S 1172—JPArc—Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, Lille, France
17Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor, Département de Pathologie, Créteil, France
18INSERM U955 Équipe 9, Université Paris Est, Créteil, France
19Département d’Hématologie Clinique et INSERM U1245, Centre Henri Becquerel, Rouen, France
20Université de Lyon, Université Lyon 1, Faculté de Pharmacie Rockefeller, 69373 Lyon Cedex, France
21CRCINA, INSERM, CNRS, Université de Nantes, Université d’Angers, Nantes, France.
Correspondence: Elizabeth Macintyre (e-mail: elizabeth.macintyre@aphp.fr).
Citation: Sujobert P, Le Bris Y, de Leval L, Gros A, Merlio JP, Pastoret C, Huet S, Sarkozy C, Davi F, Callanan M, Thieblemont C, Sibon D, Asnafi V, Preudhomme C, Gaulard P, Jardin F, Salles G, Macintyre E. The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies. HemaSphere, 2018;00:00. http://dx.doi.org/10.1097/HS9.0000000000000169.
Funding/support: None.
Disclosure: The authors have indicated they have no potential conflicts of interest to disclose.
All authors contributed to establishment of the recommendations. PS and EM wrote the paper. All the authors approved the paper.
Supplemental Digital Content is available for this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.hemaspherejournal.com).
This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
Received November 5, 2018
Accepted November 27, 2018